US Patent Issued to AMNEAL PHARMACEUTICALS on Aug. 12 for "Baclofen formulations and methods of minimizing patient exposure to metabolite variations" (Irish, American, German Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,522, issued on Aug. 12, was assigned to AMNEAL PHARMACEUTICALS LLC (Bridgewater, N.J.).

"Baclofen formulations and methods of minimizing patient exposure to metabolite variations" was invented by Leonard O'Mahony (Westmeath, Ireland), Sharon Hamm (Odessa, Fla.), John Devane (Dublin), David Penake (Atlanta), Wolfgang Mohr (Freiburg, Germany) and Manuel Weinheimer (Neustadt an der Weinstrasse, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Baclofen formulations, including formulations that minimize variability between doses, that minimize variation in patient exposure to baclofen metabolites, and are bioequivalent in regards to baclofen versus...